Lindbrook Capital’s Precision BioSciences DTIL Stock Holding History

Lindbrook Capital’s Portfolio DTIL Stock Details DTIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-21	Closed	-$5K	–	2503
2021 Q4	$5K	Buy	21 +6	+40%	+$1.68K	﹤0.01%	1498
2021 Q3	$5K	Hold	15	–	–	﹤0.01%	1232
2021 Q2	$6K	Hold	15	–	–	﹤0.01%	1232
2021 Q1	$5K	Hold	15	–	–	﹤0.01%	1248
2020 Q4	$4K	Buy	15 +11	+275%	+$2.7K	﹤0.01%	1243
2020 Q3	$1K	Buy	+4	New	+$796	﹤0.01%	1536
2020 Q2	–	Sell	-6	Closed	-$1K	–	1757
2020 Q1	$1K	Buy	6 +4	+200%	+$1.05K	﹤0.01%	1432
2019 Q4	$1K	Buy	+2	New	+$628	﹤0.01%	1371

Other funds holding DTIL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

OMC

OUP Management Company Bala Cynwyd, Pennsylvania $44.5M AUM 55.11% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Lindbrook Capital's DTIL Position: Q1 2022 in Review

Lindbrook Capital sold out of Precision BioSciences (DTIL) in Q1 2022, closing a stake of 21 shares — an estimated $5K sold.

Lindbrook Capital first reported a position in DTIL in Q4 2019 and held it in 8 quarters. The position peaked at $6K in Q2 2021. 152 funds tracked by Wall St. Rank hold DTIL as of Q1 2022.

Lindbrook Capital reported no remaining Precision BioSciences position as of Q1 2022 after selling out during the quarter.
Lindbrook Capital sold 21 Precision BioSciences shares in Q1 2022, an estimated $5K.
Lindbrook Capital first reported a position in Precision BioSciences in Q4 2019 and held it in 8 quarters.
Lindbrook Capital's Precision BioSciences position peaked at $6K in Q2 2021.
152 funds tracked by Wall St. Rank held Precision BioSciences as of Q1 2022.

Based on Lindbrook Capital's 13F filing for Q1 2022, filed 21 Apr 2022.